You are here:Home-Chemical Inhibitors & Agonists-Immunology/Inflammation-Toll-like Receptor (TLR)-CU-CPT22
CU-CPT22

Chemical Structure : CU-CPT22

CAS No.: 1416324-85-0

CU-CPT22 (CU-CPT 22)

Catalog No.: PC-38135Not For Human Use, Lab Use Only.

CU-CPT22 is a specific small-molecule inhibitor of the TLR1/TLR2 complex with IC50 of 0.58 uM (NO production in RAW 264.7 cells).

Packing Price Stock Quantity
5 mg $118 In stock
10 mg $188 In stock
25 mg $328 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

CU-CPT22 is a specific small-molecule inhibitor of the TLR1/TLR2 complex with IC50 of 0.58 uM (NO production in RAW 264.7 cells).
CU-CPT22 preferentially inhibits TLR2/1 signaling, without affecting a panel of homologous TLRs (TLR2/6, TLR3, TLR4, and TLR7).
CU-CPT22 competes with the synthetic triacylated lipoprotein (Pam3CSK4) binding to TLR1/2 with high inhibitory activity and specificity.
CU-CPT22 demonstrated minimal non-specific inhibition against a panel of 10 representative kinases (PDGFRB, MET, DDR2, SRC, MAPK1, PAK1, AKT1, PKC-γ, CAMK1, and PLK4).
CU-CPT22 also inhibits the downstream signaling transduction in cellular assays, inhibits TNF-α (60%) and IL-1β (95%) at 8 uM in the Pam3CSK4-activated RAW 264.7 cells.
CU-CPT22 reduced the nuclear translocation of NF-κB and secretion of TNF-α from cultured primary mouse microglia.
CU-CPT22 also inhibits the downstream signaling transduction in cellular assays, inhibits TNF-α (60%) and IL-1β (95%) at 8 uM in the Pam3CSK4-activated RAW 264.7 cells.

Physicochemical Properties

M.Wt 362.378
Formula C19H22O7
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 1 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

Hexyl 3,4,6-trihydroxy-2-methoxy-5-oxo-5H-benzo[7]annulene-8-carboxylate

References

1. Cheng K, et al. Angew Chem Int Ed Engl. 2012 Dec 3;51(49):12246-9.

2. Daniele SG, et al. Sci Signal. 2015 May 12;8(376):ra45.

3. Bock S, et al. Pharmacol Res. 2016 Mar;105:44-53.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: